Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 481 entries
Sorted by: Best Match Show Resources per page
Making space for graduate student parents: Practice and politics

graduate

Springer KW, Parker BK.
GSID: T2gHEbYuEOoJ
KW Springer, BK Parker… - Journal of Family …, 2009 - journals.sagepub.com

… of graduate students as idealized workers. We then present results of a survey about parental supports for graduate … , and graduate directors are often unaware of university services for …

Cite
Springer, K. W., Parker, B. K., & Leviten-Reid, C. (2009). Making space for graduate student parents: Practice and politics. Journal of Family Issues, 30(4), 435-457.
Springer, Kristen W., Brenda K. Parker, and Catherine Leviten-Reid. "Making space for graduate student parents: Practice and politics." Journal of Family Issues 30.4 (2009): 435-457.
Copy Download .nbib Format: MLA
Two Bioactive Molecular Weight Fractions of a Conditioned Medium Enhance RPE Cell Survival on Age-Related Macular Degeneration and Aged Bruch's Membrane.

Translational vision science & technology

Sugino IK, Sun Q, Springer C, Cheewatrakoolpong N, Liu T, Li H, Zarbin MA.
PMID: 26933521
Transl Vis Sci Technol. 2016 Feb 22;5(1):8. doi: 10.1167/tvst.5.1.8. eCollection 2016 Feb.

PURPOSE: To characterize molecular weight fractions of bovine corneal endothelial cell conditioned medium (CM) supporting retinal pigment epithelium (RPE) cell survival on aged and age-related macular degeneration (AMD) Bruch's membrane.METHODS: CM was subject to size separation using centrifugal filters....

Cite
Sugino IK, Sun Q, Springer C, et al. Two Bioactive Molecular Weight Fractions of a Conditioned Medium Enhance RPE Cell Survival on Age-Related Macular Degeneration and Aged Bruch's Membrane. Transl Vis Sci Technol. 2016;5(1):8doi: 10.1167/tvst.5.1.8.
Sugino, I. K., Sun, Q., Springer, C., Cheewatrakoolpong, N., Liu, T., Li, H., & Zarbin, M. A. (2016). Two Bioactive Molecular Weight Fractions of a Conditioned Medium Enhance RPE Cell Survival on Age-Related Macular Degeneration and Aged Bruch's Membrane. Translational vision science & technology, 5(1), 8. https://doi.org/10.1167/tvst.5.1.8
Sugino, Ilene K, et al. "Two Bioactive Molecular Weight Fractions of a Conditioned Medium Enhance RPE Cell Survival on Age-Related Macular Degeneration and Aged Bruch's Membrane." Translational vision science & technology vol. 5,1 (2016): 8. doi: https://doi.org/10.1167/tvst.5.1.8
Sugino IK, Sun Q, Springer C, Cheewatrakoolpong N, Liu T, Li H, Zarbin MA. Two Bioactive Molecular Weight Fractions of a Conditioned Medium Enhance RPE Cell Survival on Age-Related Macular Degeneration and Aged Bruch's Membrane. Transl Vis Sci Technol. 2016 Feb 22;5(1):8. doi: 10.1167/tvst.5.1.8. eCollection 2016 Feb. PMID: 26933521; PMCID: PMC4771074.
Copy Download .nbib Format: NLM
A competitive trade-off limits the selective advantage of increased antibiotic production.

Nature microbiology

Gerardin Y, Springer M, Kishony R.
PMID: 27668360
Nat Microbiol. 2016 Sep 26;1:16175. doi: 10.1038/nmicrobiol.2016.175.

In structured environments, antibiotic-producing microorganisms can gain a selective advantage by inhibiting nearby competing species

Cite
Gerardin Y, Springer M, Kishony R. A competitive trade-off limits the selective advantage of increased antibiotic production. Nat Microbiol. 2016;1:16175doi: 10.1038/nmicrobiol.2016.175.
Gerardin, Y., Springer, M., & Kishony, R. (2016). A competitive trade-off limits the selective advantage of increased antibiotic production. Nature microbiology, 116175. https://doi.org/10.1038/nmicrobiol.2016.175
Gerardin, Ylaine, et al. "A competitive trade-off limits the selective advantage of increased antibiotic production." Nature microbiology vol. 1 (2016): 16175. doi: https://doi.org/10.1038/nmicrobiol.2016.175
Gerardin Y, Springer M, Kishony R. A competitive trade-off limits the selective advantage of increased antibiotic production. Nat Microbiol. 2016 Sep 26;1:16175. doi: 10.1038/nmicrobiol.2016.175. PMID: 27668360; PMCID: PMC5046839.
Copy Download .nbib Format: NLM
Six1 is down-regulated in end-stage human dilated cardiomyopathy independently of Ezh2.

ESC heart failure

Tschirner A, Palus S, Hetzer R, Meyer R, Anker SD, Springer J.
PMID: 27668088
ESC Heart Fail. 2014 Dec;1(2):154-159. doi: 10.1002/ehf2.12017. Epub 2015 Jan 22.

BACKGROUND: Recently, it was shown that a knock-out (KO) of the polycomb histone methyltransferase Ezh2 leads to cardiac hypertrophy in mice, which was driven by the homeodomain transcription factor Six1. Here, we analyzed the expression of Six1 and its...

Cite
Tschirner A, Palus S, Hetzer R, et al. Six1 is down-regulated in end-stage human dilated cardiomyopathy independently of Ezh2. ESC Heart Fail. 2015;1(2):154-159doi: 10.1002/ehf2.12017.
Tschirner, A., Palus, S., Hetzer, R., Meyer, R., Anker, S. D., & Springer, J. (2014). Six1 is down-regulated in end-stage human dilated cardiomyopathy independently of Ezh2. ESC heart failure, 1(2), 154-159. https://doi.org/10.1002/ehf2.12017
Tschirner, Anika, et al. "Six1 is down-regulated in end-stage human dilated cardiomyopathy independently of Ezh2." ESC heart failure vol. 1,2 (2014): 154-159. doi: https://doi.org/10.1002/ehf2.12017
Tschirner A, Palus S, Hetzer R, Meyer R, Anker SD, Springer J. Six1 is down-regulated in end-stage human dilated cardiomyopathy independently of Ezh2. ESC Heart Fail. 2014 Dec;1(2):154-159. doi: 10.1002/ehf2.12017. Epub 2015 Jan 22. PMID: 27668088; PMCID: PMC5024036.
Copy Download .nbib Format: NLM
Stiff, light, strong and ductile: nano-structured High Modulus Steel.

Scientific reports

Springer H, Baron C, Szczepaniak A, Uhlenwinkel V, Raabe D, Benasich AA, Brooks-Gunn J.
PMID: 28584234
Sci Rep. 2017 Jun 05;7(1):2757. doi: 10.1038/s41598-017-02861-3.

Structural material development for lightweight applications aims at improving the key parameters strength, stiffness and ductility at low density, but these properties are typically mutually exclusive. Here we present how we overcome this trade-off with a new class of...

Cite
Springer H, Baron C, Szczepaniak A, et al. Stiff, light, strong and ductile: nano-structured High Modulus Steel. Sci Rep. 2017;7(1):2757doi: 10.1038/s41598-017-02861-3.
Springer, H., Baron, C., Szczepaniak, A., Uhlenwinkel, V., Raabe, D., Benasich, A. A., & Brooks-Gunn, J. (2017). Stiff, light, strong and ductile: nano-structured High Modulus Steel. Scientific reports, 7(1), 2757. https://doi.org/10.1038/s41598-017-02861-3
Springer, H, et al. "Stiff, light, strong and ductile: nano-structured High Modulus Steel." Scientific reports vol. 7,1 (2017): 2757. doi: https://doi.org/10.1038/s41598-017-02861-3
Springer H, Baron C, Szczepaniak A, Uhlenwinkel V, Raabe D, Benasich AA, Brooks-Gunn J. Stiff, light, strong and ductile: nano-structured High Modulus Steel. Sci Rep. 2017 Jun 05;7(1):2757. doi: 10.1038/s41598-017-02861-3. PMID: 28584234; PMCID: PMC5459840.
Copy Download .nbib Format: NLM
Hospital Law Review: Recent Rulings on Staff Privileges.

Hospital topics

Springer EW.
PMID: 28142578
Hosp Top. 1972 Sep;50(9):57-74. doi: 10.1080/00185868.1972.9952326.

No abstract available.

Cite
Springer EW. Hospital Law Review: Recent Rulings on Staff Privileges. Hosp Top. 1972;50(9):57-74doi: 10.1080/00185868.1972.9952326.
Springer, E. W. (1972). Hospital Law Review: Recent Rulings on Staff Privileges. Hospital topics, 50(9), 57-74. https://doi.org/10.1080/00185868.1972.9952326
Springer, Eric W. "Hospital Law Review: Recent Rulings on Staff Privileges." Hospital topics vol. 50,9 (1972): 57-74. doi: https://doi.org/10.1080/00185868.1972.9952326
Springer EW. Hospital Law Review: Recent Rulings on Staff Privileges. Hosp Top. 1972 Sep;50(9):57-74. doi: 10.1080/00185868.1972.9952326. PMID: 28142578.
Copy Download .nbib Format: NLM
Hospital Law Review.

Hospital topics

Springer EW.
PMID: 26600028
Hosp Top. 1972 Nov;50(11):36-37. doi: 10.1080/00185868.1972.9947969.

No abstract available.

Cite
Springer EW. Hospital Law Review. Hosp Top. 1972;50(11):36-37doi: 10.1080/00185868.1972.9947969.
Springer, E. W. (1972). Hospital Law Review. Hospital topics, 50(11), 36-37. https://doi.org/10.1080/00185868.1972.9947969
Springer, Eric W. "Hospital Law Review." Hospital topics vol. 50,11 (1972): 36-37. doi: https://doi.org/10.1080/00185868.1972.9947969
Springer EW. Hospital Law Review. Hosp Top. 1972 Nov;50(11):36-37. doi: 10.1080/00185868.1972.9947969. PMID: 26600028.
Copy Download .nbib Format: NLM
Concern regarding quality and quality of muscle.

Journal of cachexia, sarcopenia and muscle

Saitoh M, Ishida J, Konishi M, Springer J.
PMID: 26674583
J Cachexia Sarcopenia Muscle. 2015 Dec;6(4):394-5. doi: 10.1002/jcsm.12081. Epub 2015 Nov 03.

No abstract available.

Cite
Saitoh M, Ishida J, Konishi M, et al. Concern regarding quality and quality of muscle. J Cachexia Sarcopenia Muscle. 2015;6(4):394-5doi: 10.1002/jcsm.12081.
Saitoh, M., Ishida, J., Konishi, M., & Springer, J. (2015). Concern regarding quality and quality of muscle. Journal of cachexia, sarcopenia and muscle, 6(4), 394-5. https://doi.org/10.1002/jcsm.12081
Saitoh, Masakazu, et al. "Concern regarding quality and quality of muscle." Journal of cachexia, sarcopenia and muscle vol. 6,4 (2015): 394-5. doi: https://doi.org/10.1002/jcsm.12081
Saitoh M, Ishida J, Konishi M, Springer J. Concern regarding quality and quality of muscle. J Cachexia Sarcopenia Muscle. 2015 Dec;6(4):394-5. doi: 10.1002/jcsm.12081. Epub 2015 Nov 03. PMID: 26674583; PMCID: PMC4670750.
Copy Download .nbib Format: NLM
Hypermetabolism: should cancer types, pathological stages and races be considered in assessing metabolism and could elevated resting energy expenditure be the therapeutic target in patients with advanced cancer?.

Journal of cachexia, sarcopenia and muscle

Ishida J, Konishi M, Saito M, Springer J.
PMID: 26674220
J Cachexia Sarcopenia Muscle. 2015 Dec;6(4):391-2. doi: 10.1002/jcsm.12080. Epub 2015 Oct 27.

No abstract available.

Cite
Ishida J, Konishi M, Saito M, et al. Hypermetabolism: should cancer types, pathological stages and races be considered in assessing metabolism and could elevated resting energy expenditure be the therapeutic target in patients with advanced cancer?. J Cachexia Sarcopenia Muscle. 2015;6(4):391-2doi: 10.1002/jcsm.12080.
Ishida, J., Konishi, M., Saito, M., & Springer, J. (2015). Hypermetabolism: should cancer types, pathological stages and races be considered in assessing metabolism and could elevated resting energy expenditure be the therapeutic target in patients with advanced cancer?. Journal of cachexia, sarcopenia and muscle, 6(4), 391-2. https://doi.org/10.1002/jcsm.12080
Ishida, Junichi, et al. "Hypermetabolism: should cancer types, pathological stages and races be considered in assessing metabolism and could elevated resting energy expenditure be the therapeutic target in patients with advanced cancer?." Journal of cachexia, sarcopenia and muscle vol. 6,4 (2015): 391-2. doi: https://doi.org/10.1002/jcsm.12080
Ishida J, Konishi M, Saito M, Springer J. Hypermetabolism: should cancer types, pathological stages and races be considered in assessing metabolism and could elevated resting energy expenditure be the therapeutic target in patients with advanced cancer?. J Cachexia Sarcopenia Muscle. 2015 Dec;6(4):391-2. doi: 10.1002/jcsm.12080. Epub 2015 Oct 27. PMID: 26674220; PMCID: PMC4670748.
Copy Download .nbib Format: NLM
Novel mechanism of ghrelin therapy for cachexia.

Journal of cachexia, sarcopenia and muscle

Hatanaka M, Konishi M, Ishida J, Saito M, Springer J.
PMID: 26674390
J Cachexia Sarcopenia Muscle. 2015 Dec;6(4):393. doi: 10.1002/jcsm.12084. Epub 2015 Oct 27.

No abstract available.

Cite
Hatanaka M, Konishi M, Ishida J, et al. Novel mechanism of ghrelin therapy for cachexia. J Cachexia Sarcopenia Muscle. 2015;6(4):393doi: 10.1002/jcsm.12084.
Hatanaka, M., Konishi, M., Ishida, J., Saito, M., & Springer, J. (2015). Novel mechanism of ghrelin therapy for cachexia. Journal of cachexia, sarcopenia and muscle, 6(4), 393. https://doi.org/10.1002/jcsm.12084
Hatanaka, Michiyoshi, et al. "Novel mechanism of ghrelin therapy for cachexia." Journal of cachexia, sarcopenia and muscle vol. 6,4 (2015): 393. doi: https://doi.org/10.1002/jcsm.12084
Hatanaka M, Konishi M, Ishida J, Saito M, Springer J. Novel mechanism of ghrelin therapy for cachexia. J Cachexia Sarcopenia Muscle. 2015 Dec;6(4):393. doi: 10.1002/jcsm.12084. Epub 2015 Oct 27. PMID: 26674390; PMCID: PMC4670749.
Copy Download .nbib Format: NLM
SU-E-I-29: Dose Rate and Image Quality Comparison Between Philips Veradius and GE OEC 9900 Elite Fluoroscopic C-Arms.

Medical physics

Springer A, Solem E, Kobistek R.
PMID: 28519531
Med Phys. 2012 Jun;39(6):3631. doi: 10.1118/1.4734744.

PURPOSE: The radiation dose rate and image quality were compared on GE OEC 9900 Elite Vas 8 and Philips Veradius fluoroscopic C-arms.METHODS: Plastic (PMMA) phantoms were used to simulate various thicknesses of soft tissues encountered during fluoroscopically-guided interventional procedures...

Cite
Springer A, Solem E, Kobistek R. SU-E-I-29: Dose Rate and Image Quality Comparison Between Philips Veradius and GE OEC 9900 Elite Fluoroscopic C-Arms. Med Phys. 2012;39(6):3631doi: 10.1118/1.4734744.
Springer, A., Solem, E., & Kobistek, R. (2012). SU-E-I-29: Dose Rate and Image Quality Comparison Between Philips Veradius and GE OEC 9900 Elite Fluoroscopic C-Arms. Medical physics, 39(6), 3631. https://doi.org/10.1118/1.4734744
Springer, A, et al. "SU-E-I-29: Dose Rate and Image Quality Comparison Between Philips Veradius and GE OEC 9900 Elite Fluoroscopic C-Arms." Medical physics vol. 39,6 (2012): 3631. doi: https://doi.org/10.1118/1.4734744
Springer A, Solem E, Kobistek R. SU-E-I-29: Dose Rate and Image Quality Comparison Between Philips Veradius and GE OEC 9900 Elite Fluoroscopic C-Arms. Med Phys. 2012 Jun;39(6):3631. doi: 10.1118/1.4734744. PMID: 28519531.
Copy Download .nbib Format: NLM
Draft Genome Sequence of a Community-Acquired Methicillin-Resistant .

Genome announcements

Lepuschitz S, Mach R, Springer B, Allerberger F, Ruppitsch W.
PMID: 29051260
Genome Announc. 2017 Oct 19;5(42). doi: 10.1128/genomeA.01166-17.

The increasing emergence of multiresistant bacteria in health care settings in the community and in the environment represents a major health threat worldwide. Here, we report the draft genome sequence of a community-acquired methicillin-resistant

Cite
Lepuschitz S, Mach R, Springer B, et al. Draft Genome Sequence of a Community-Acquired Methicillin-Resistant . Genome Announc. 2017;5(42)doi: 10.1128/genomeA.01166-17.
Lepuschitz, S., Mach, R., Springer, B., Allerberger, F., & Ruppitsch, W. (2017). Draft Genome Sequence of a Community-Acquired Methicillin-Resistant . Genome announcements, 5(42), . https://doi.org/10.1128/genomeA.01166-17
Lepuschitz, Sarah, et al. "Draft Genome Sequence of a Community-Acquired Methicillin-Resistant ." Genome announcements vol. 5,42 (2017). doi: https://doi.org/10.1128/genomeA.01166-17
Lepuschitz S, Mach R, Springer B, Allerberger F, Ruppitsch W. Draft Genome Sequence of a Community-Acquired Methicillin-Resistant . Genome Announc. 2017 Oct 19;5(42). doi: 10.1128/genomeA.01166-17. PMID: 29051260; PMCID: PMC5646413.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 481 entries